Page last updated: 2024-08-18

thiophenes and Pulmonary Embolism

thiophenes has been researched along with Pulmonary Embolism in 90 studies

Research

Studies (90)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (1.11)	18.7374
1990's	0 (0.00)	18.2507
2000's	12 (13.33)	29.6817
2010's	77 (85.56)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Badolia, R; Borst, O; Campbell, RA; Kunapuli, SP; Manne, BK; Middleton, E; Münzer, P; Rondina, MT; Walker-Allgaier, B; Weyrich, AS	1
Guijarro Merino, R; Villalobos Sánchez, A	1
Holley, AB; King, CS; Moores, LK	1
Forster, MC; Goodson, MW; Rath, NK; White, SP	1
Aung, TH; Foo, D; Francis, PJ; Ho, HH; Huang, W; Ong, PJ; Wong, CP; Yeo, D	1
Vanassche, T; Verhamme, P	1
Bates, P; Culpan, P; El-Daly, I; Reidy, J	1
Wanat, MA	1
Dachs, R; Endres, J; Graber, MA	1
Agnelli, G; Becattini, C; Franco, L	1
Eriksson, BI; Quinlan, DJ	1
Cohen, AA; Rider, T	1
Lu, WX; Qin, L	1
Atar, D; Ghanima, W; Sandset, PM	1
Barbar, S; Milan, M; Pesavento, R; Prandoni, P; Vedovetto, V	1
Bay, C; Schwartz, F; Sharifi, M; Skrocki, L	1
Wood, P	1
Baruch, L; Sherman, O	1
Risselada, AJ; van Roon, E; Visser, MJ	1
Burness, CB; Perry, CM	1
Bamber, L; Correa de Carvalho, F; Lensing, AW; Prins, M; van Bellen, B; Wang, M	1
Du, EX; Li, N; Liu, Y; Tan, R; Wu, C; Wu, EQ; Xie, J	1
Bounameaux, H; Fontana, P; Goldhaber, SZ	1
Dankoff, J; Kuuskne, M	1
Bookhart, B; Huynh, L; Lefebvre, P; Mody, SH; Tran, KN; Zhuo, DY	1
Chatterjee, S; Ghosh, J; Giri, JS; Mukherjee, D; Sardar, P	1
Cappato, R; Davies, DW; Fields, LE; Hess, S; Hohnloser, SH; Ma, C; Marchlinski, FE; Naccarelli, GV; Natale, A; Wilber, DJ; Xiang, J	1
Bamber, L; Bookhart, BK; Haskell, L; Mody, SH; Schein, J; Wang, M	1
Akwaa, F; Spyropoulos, AC	1
Dupree, LH; Reddy, P	1
Conway, SE; Mitchell, AP	1
Koracevic, GP	2
Aupetit, JF; Chaudesaygues, E; Grasse, M; Marchand, L; Villar, E	1
Bolland, MJ; Grey, A	1
Berghold, A; Kemperdick, B; Mergenthal, K; Petersen, JJ; Rauck, S; Roehl, I; Schulz-Rothe, S; Siebenhofer, A; Ulrich, LR	1
Bamber, L; Bauersachs, R; Cano, SJ; Erkens, P; Lensing, AW; Prins, MH; Wang, MY	1
Kartasheva, ED; Shevchenko, IuL; Stoĭko, IuM; Zamiatin, MN	1
Feuerstein, JD; Ketwaroo, GA; Leffler, DA; Patwardhan, VR; Sengupta, N; Tapper, EB; Thaker, AM	1
Bultas, J; Karetová, D	1
Caffrey, MK	1
Erkens, PM; Fermann, GJ; Lensing, AW; Pap, ÁF; Prins, MH; Wells, PS	1
Arnheim, K	1
Bächli, E; Walti, C	1
Feng, W; Lin, Y; Lu, H; Xi, AM; Yan, CZ; Zhang, Y	1
Undas, A	1
Ciurzyński, M; Paczyńska, M; Pruszczyk, P; Sobieraj, P	1
Chen, B; Huang, CC; Kuo, FC; Lin, PC; Wang, JW; Yen, SH	1
Bansal, VB; Donovan, A; Gollish, JD; Gomez, D; Murnaghan, JJ; Razmjou, H	1
Cushner, FD; Eriksson, BI; Friedman, RJ; Lassen, MR	1
Bandel, TJ; Beckmann, H; Borris, LC; Eriksson, BI; Friedman, RJ; Geerts, W; Haas, S; Huisman, MV; Kakkar, AK; Misselwitz, F; Muehlhofer, E	1
Ageno, W; Bandel, TJ; Borris, LC; Lassen, MR; Lieberman, JR; Misselwitz, F; Rosencher, N; Turpie, AG	1
Lotke, PA	1
Samama, CM	1
Tripodi, A; van den Besselaar, A	1
Brighton, TA; Verma, AK	1
Mosekilde, L; Pinholt, EM; Rejnmark, L; Schwartz, K; Vestergaard, P	1
Lowenthal, DT; Sattari, M	1
Agnelli, G; Bauersachs, R; Berkowitz, SD; Bounameaux, H; Brenner, B; Buller, HR; Cohen, A; Davidson, BL; Decousus, H; Gallus, AS; Lensing, AW; Misselwitz, F; Piovella, F; Prins, MH; Raskob, GE; Schellong, S; Segers, A; Verhamme, P; Wells, P	1
Kwok, CS; Loke, YK	1
Büller, HR; Cohen, AT; Haskell, L; Hu, D; Hull, R; Mebazaa, A; Merli, G; Schellong, S; Spiro, TE; Spyropoulos, A; Tapson, V	1
Gans, RO; Landman, GW	1
Keltai, K; Keltai, M	1
Thompson, CA	1
Muñoz-Torrero, JF; Zamorano, J	1
Galanis, T; Kraft, WK; Merli, GJ	1
Combe, S; Conard, J; Flaujac, C; Horellou, MH; Samamaa, MM	1
Büller, HR; Combe, S	1
Cid, A; Godoy Monzon, D; Iserson, KV; Vazquez, JA	1
Bertol, E; Gualco, B; Mari, F; Rensi, R	1
Agnelli, G; Berkowitz, SD; Bounameaux, H; Büller, HR; Chlumsky, J; Cohen, A; Davidson, BL; Decousus, H; Gallus, AS; Jacobson, BF; Lensin, AW; Minar, E; Misselwitz, F; Prins, MH; Raskob, GE; Schellong, S; Segers, A; Verhamme, P; Wells, P	1
Cios, D; Fanikos, J	1
Einecke, D	1
Kline, JA; Yealy, DM	1
Gibson, CM; Gopalakrishnan, L; Kohli, P; Kumar, V; Rastogi, U; Singh, P	1
O'Connell, NM; O'Donnell, DM; O'Donnell, JS	1
Bhaskar, E	1
Bobbia, X; Claret, PG; de la Coussaye, JE	1
DeDea, L	1
Elias, A; Gaillard, C; Gouin, I; Nguyen, P; Ouvry, P; Pernod, G; Sié, P	1
Cen, X; Du, G; Fu, F; Guan, X; Li, Y; Liu, W; Tian, J; Wang, H; Ye, L; Yu, P; Yu, X; Zhang, J	1
Albuquerque, LG; Dini, GM; Ferreira, LM; Ferreira, MCC	1
Betegón Nicolás, L; de Salas-Cansado, M; Gómez Arrayas, I; Gómez Cerezo, JF; Rubio-Terrés, C; Suárez Fernández, C	1
Borris, L; Dahl, OE; Eriksson, BI; Haas, S; Huisman, MV; Kakkar, AK; Kälebo, P; Misselwitz, F	1
Bauer, KA; Borris, L; Dahl, OE; Eriksson, BI; Fisher, WD; Gent, M; Haas, S; Homering, M; Huisman, MV; Kakkar, AK; Kälebo, P; Kwong, LM; Misselwitz, F; Turpie, AG	1
Agnelli, G; Gallus, A; Goldhaber, SZ; Haas, S; Huisman, MV; Hull, RD; Kakkar, AK; Misselwitz, F; Schellong, S	1
Go, G; Gonzalez Della Valle, A; Lyman, S; Salvati, EA; Sharrock, NE	1
Evans, TR; Fullarton, GM; Garcia-Vargas, J; Harris, AL; Lofts, FJ; Mackay, HJ; McDonald, AC; McInnes, A; Paul, J; Raby, N; Soukop, M	1
Gastpar, H	1

Reviews

26 review(s) available for thiophenes and Pulmonary Embolism

Article	Year
[Prophylaxis of venous thromboembolism in orthopedic surgery. Role of the new anticoagulants]. Medicina clinica, 2012, Volume: 139 Suppl 2 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism	2012
Moving toward a more ideal anticoagulant: the oral direct thrombin and factor Xa inhibitors. Chest, 2013, Volume: 143, Issue:4 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombin	2013
Rivaroxaban for the treatment of pulmonary embolism. Advances in therapy, 2013, Volume: 30, Issue:6 Topics: Administration, Oral; Anticoagulants; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thrombosis	2013
Thromboprophylaxis in patients with pelvic and acetabular fractures: A short review and recommendations. Injury, 2013, Volume: 44, Issue:12 Topics: Acetabulum; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Coumarins; Dabigatran; Fondaparinux; Fractures, Bone; Heparin; Humans; Mass Screening; Morpholines; Multiple Trauma; Pelvis; Polysaccharides; Pulmonary Embolism; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thiophenes; Vena Cava Filters; Venous Thromboembolism	2013
Novel oral anticoagulants: a review of new agents. Postgraduate medicine, 2013, Volume: 125, Issue:4 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Humans; Morpholines; Postoperative Complications; Practice Guidelines as Topic; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2013
New oral anticoagulants for the treatment of venous thromboembolism. Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2 Topics: Administration, Oral; Adult; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Humans; Middle Aged; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Thiophenes; Venous Thromboembolism; Warfarin	2013
Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery. Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2 Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Heparin, Low-Molecular-Weight; Humans; Morpholines; Postoperative Hemorrhage; Pulmonary Embolism; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Venous Thromboembolism; Warfarin	2013
NOACs for thromboprophylaxis in medical patients. Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2 Topics: Administration, Oral; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Enoxaparin; Humans; Morpholines; Postoperative Hemorrhage; Pulmonary Embolism; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Surgical Procedures, Operative; Thiophenes; Venous Thromboembolism; Warfarin	2013
[Advances in venous thromboembolism]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2013, Volume: 36, Issue:5 Topics: Anticoagulants; Hemorrhage; Heparin; Humans; Magnetic Resonance Angiography; Morpholines; Pulmonary Artery; Pulmonary Embolism; Rivaroxaban; Thiophenes; Thrombolytic Therapy; Tomography, X-Ray Computed; Venous Thromboembolism	2013
New oral anticoagulants--a review. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2013, Oct-01, Volume: 133, Issue:18 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Medication Adherence; Morpholines; Practice Guidelines as Topic; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2013
The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities. European journal of internal medicine, 2014, Volume: 25, Issue:1 Topics: Age Factors; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Disease Management; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Fondaparinux; Humans; Male; Morpholines; Obesity; Polysaccharides; Postthrombotic Syndrome; Pulmonary Embolism; Risk Assessment; Risk Factors; Rivaroxaban; Secondary Prevention; Sex Factors; Thiophenes; Thrombophilia; Ultrasonography; Venous Thromboembolism; Venous Thrombosis; Warfarin	2014
Rivaroxaban: a review of its use in the treatment of deep vein thrombosis or pulmonary embolism and the prevention of recurrent venous thromboembolism. Drugs, 2014, Volume: 74, Issue:2 Topics: Anticoagulants; Factor Xa Inhibitors; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Secondary Prevention; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2014
Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism. European heart journal, 2014, Jul-21, Volume: 35, Issue:28 Topics: Acute Disease; Administration, Oral; Antithrombins; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Hemorrhage; Humans; Long-Term Care; Morpholines; Perioperative Care; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Treatment Outcome; Venous Thromboembolism; Vitamin K	2014
Treatment discontinuations with new oral agents for long-term anticoagulation: insights from a meta-analysis of 18 randomized trials including 101,801 patients. Mayo Clinic proceedings, 2014, Volume: 89, Issue:7 Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Medication Adherence; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism	2014
The potential of target-specific oral anticoagulants for the acute and long-term treatment of venous thromboembolism. Current medical research and opinion, 2014, Volume: 30, Issue:11 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2014
Rivaroxaban for treatment of venous thromboembolism in older adults. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2014, Volume: 29, Issue:9 Topics: Aged; Aged, 80 and over; Aging; Factor Xa Inhibitors; Humans; Kidney; Morpholines; Pulmonary Embolism; Recurrence; Renal Insufficiency; Rivaroxaban; Thiophenes; Venous Thromboembolism	2014
A comparison of adverse event and fracture efficacy data for strontium ranelate in regulatory documents and the publication record. BMJ open, 2014, Oct-07, Volume: 4, Issue:10 Topics: Bone Density Conservation Agents; Drug and Narcotic Control; Humans; Myocardial Infarction; Osteoporosis; Osteoporotic Fractures; Periodicals as Topic; Pulmonary Embolism; Research Report; Risk Assessment; Thiophenes; Venous Thromboembolism	2014
[Direct acting oral anticoagulants in venous thromboembolism]. Praxis, 2015, Jul-22, Volume: 104, Issue:15 Topics: Administration, Oral; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Contraindications; Dabigatran; Drug Interactions; Humans; International Normalized Ratio; Male; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Thiophenes; Venous Thromboembolism	2015
[Perioperative venous thromboembolism prophylaxis: short review and recommendations]. Annales francaises d'anesthesie et de reanimation, 2008, Volume: 27 Suppl 3 Topics: Adult; Aged; Anticoagulants; Combined Modality Therapy; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Middle Aged; Morpholines; Polysaccharides; Postoperative Complications; Preanesthetic Medication; Pulmonary Embolism; Risk Factors; Rivaroxaban; Stockings, Compression; Thiophenes; Thromboembolism; Thrombophlebitis; Vitamin K	2008
Laboratory monitoring of anticoagulation: where do we stand? Seminars in thrombosis and hemostasis, 2009, Volume: 35, Issue:1 Topics: Anticoagulants; Blood Coagulation; Clinical Trials as Topic; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Incidence; International Normalized Ratio; Monitoring, Physiologic; Morpholines; Polysaccharides; Prothrombin Time; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Vitamin K	2009
Novel oral anticoagulants in development: Dabigatran, Rivaroxaban, and Apixaban. American journal of therapeutics, 2011, Volume: 18, Issue:4 Topics: Administration, Oral; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Dabigatran; Drug Approval; Humans; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; United States; Venous Thrombosis	2011
Dabigatran and rivaroxaban for prevention of venous thromboembolism--systematic review and adjusted indirect comparison. Journal of clinical pharmacy and therapeutics, 2011, Volume: 36, Issue:1 Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Enoxaparin; Factor Xa Inhibitors; Hemorrhage; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2011
Prophylaxis for deep vein thrombosis and pulmonary embolism in the surgical patient. Advances in surgery, 2011, Volume: 45 Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Heparin; Heparin, Low-Molecular-Weight; Humans; Intermittent Pneumatic Compression Devices; Morpholines; Neurosurgical Procedures; Orthopedic Procedures; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stockings, Compression; Surgical Procedures, Operative; Thiophenes; Urologic Surgical Procedures; Venous Thrombosis	2011
Pharmacokinetic evaluation of rivaroxaban for the treatment of acute coronary syndromes. Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:7 Topics: Acute Coronary Syndrome; Administration, Oral; Blood Coagulation Tests; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Drug Interactions; Factor Xa; Factor Xa Inhibitors; Half-Life; Humans; Morpholines; Myocardial Infarction; Pulmonary Embolism; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Thrombin; Thrombosis	2012
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies. Thrombosis and haemostasis, 2007, Volume: 97, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Dose-Response Relationship, Drug; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Humans; Incidence; Male; Middle Aged; Morpholines; Phlebography; Pulmonary Embolism; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thrombosis	2007
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clinical orthopaedics and related research, 2008, Volume: 466, Issue:3 Topics: Anesthesia, Conduction; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Azetidines; Benzylamines; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Intermittent Pneumatic Compression Devices; Morpholines; Platelet Aggregation Inhibitors; Polysaccharides; Pulmonary Embolism; Risk Assessment; Risk Factors; Rivaroxaban; Thiophenes; Treatment Outcome; Warfarin	2008

Trials

15 trial(s) available for thiophenes and Pulmonary Embolism

Article	Year
Reduction in the length of stay with rivaroxaban as a single-drug regimen for the treatment of deep vein thrombosis and pulmonary embolism. Current medical research and opinion, 2014, Volume: 30, Issue:5 Topics: Anticoagulants; Enoxaparin; Female; Humans; Length of Stay; Male; Middle Aged; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thrombosis; Vitamin K	2014
Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2014, Volume: 41, Issue:2 Topics: Adult; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Morpholines; Patient Safety; Postoperative Care; Preoperative Care; Prospective Studies; Pulmonary Embolism; Rivaroxaban; Statistics, Nonparametric; Survival Rate; Thiophenes; Treatment Outcome; Venous Thrombosis; Vitamin K; Warfarin	2014
Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trial. Thrombosis research, 2015, Volume: 135, Issue:2 Topics: Administration, Oral; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Morpholines; Patient Satisfaction; Pulmonary Embolism; Rivaroxaban; Thiophenes	2015
Treatment of pulmonary embolism with rivaroxaban: outcomes by simplified Pulmonary Embolism Severity Index score from a post hoc analysis of the EINSTEIN PE study. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2015, Volume: 22, Issue:3 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Comorbidity; Emergency Service, Hospital; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Predictive Value of Tests; Prognosis; Pulmonary Embolism; Risk; Rivaroxaban; Severity of Illness Index; Thiophenes	2015
The Efficacy of Combined Use of Rivaroxaban and Tranexamic Acid on Blood Conservation in Minimally Invasive Total Knee Arthroplasty a Double-Blind Randomized, Controlled Trial. The Journal of arthroplasty, 2017, Volume: 32, Issue:3 Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; Double-Blind Method; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Hematoma; Humans; Male; Middle Aged; Morpholines; Postoperative Hemorrhage; Postoperative Period; Prospective Studies; Pulmonary Embolism; Rivaroxaban; Thiophenes; Tranexamic Acid; Venous Thrombosis	2017
A Phase IV Study of Thromboembolic and Bleeding Events Following Hip and Knee Arthroplasty Using Oral Factor Xa Inhibitor. The Journal of arthroplasty, 2017, Volume: 32, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Transfusion; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Prospective Studies; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Young Adult	2017
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. The New England journal of medicine, 2008, Jun-26, Volume: 358, Issue:26 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Double-Blind Method; Enoxaparin; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2008
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. The New England journal of medicine, 2008, Jun-26, Volume: 358, Issue:26 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Double-Blind Method; Enoxaparin; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2008
Oral rivaroxaban for symptomatic venous thromboembolism. The New England journal of medicine, 2010, Dec-23, Volume: 363, Issue:26 Topics: Acenocoumarol; Acute Disease; Administration, Oral; Aged; Anticoagulants; Double-Blind Method; Enoxaparin; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Injections, Subcutaneous; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Vitamin K; Warfarin	2010
Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol. Journal of thrombosis and thrombolysis, 2011, Volume: 31, Issue:4 Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Double-Blind Method; Female; Heart Failure; Humans; Infections; Male; Middle Aged; Morpholines; Pulmonary Embolism; Respiratory Insufficiency; Risk Factors; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2011
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. The New England journal of medicine, 2012, 04-05, Volume: 366, Issue:14 Topics: Administration, Oral; Aged; Anticoagulants; Drug Therapy, Combination; Enoxaparin; Female; Follow-Up Studies; Hemorrhage; Humans; International Normalized Ratio; Kaplan-Meier Estimate; Male; Middle Aged; Morpholines; Pulmonary Embolism; Recurrence; Rivaroxaban; Thiophenes; Treatment Outcome; Vitamin K	2012
How safe is thromboprophylaxis in abdominoplasty? Plastic and reconstructive surgery, 2012, Volume: 130, Issue:6 Topics: Abdominoplasty; Administration, Oral; Adult; Anticoagulants; Double-Blind Method; Drug Administration Schedule; Early Termination of Clinical Trials; Female; Follow-Up Studies; Hematoma; Humans; Middle Aged; Morpholines; Postoperative Care; Postoperative Complications; Postoperative Hemorrhage; Prospective Studies; Pulmonary Embolism; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis	2012
Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement. Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Dose-Response Relationship, Drug; Double-Blind Method; Enoxaparin; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Pulmonary Embolism; Rivaroxaban; Thiophenes; Thromboembolism; Venous Thrombosis	2006
Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study. Circulation, 2007, Jul-10, Volume: 116, Issue:2 Topics: Administration, Oral; Adult; Anticoagulants; Factor Xa Inhibitors; Heparin; Humans; Morpholines; Patient Selection; Pulmonary Embolism; Rivaroxaban; Safety; Thiophenes; Thrombosis	2007
A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Drug Hypersensitivity; Enteritis; Epirubicin; Esophageal Neoplasms; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Pulmonary Embolism; Quinazolines; Sepsis; Stomach Neoplasms; Survival Analysis; Thiophenes; Treatment Outcome	2001

Other Studies

49 other study(ies) available for thiophenes and Pulmonary Embolism

Article	Year
PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway. Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:6 Topics: 3-Phosphoinositide-Dependent Protein Kinases; Animals; Blood Platelets; Disease Models, Animal; Humans; Mice, Knockout; Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins c-raf; Pulmonary Embolism; Pyrimidines; Signal Transduction; Thiophenes; Thrombosis; Thromboxanes	2018
The use of rivaroxaban for chemical thromboprophylaxis following total knee replacement. The Knee, 2013, Volume: 20, Issue:6 Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Case-Control Studies; Female; Follow-Up Studies; Humans; Middle Aged; Morpholines; Postoperative Complications; Primary Prevention; Pulmonary Embolism; Retrospective Studies; Risk Assessment; Rivaroxaban; Survival Rate; Thiophenes; Time Factors; Treatment Outcome; Venous Thromboembolism	2013
Successful treatment of a patient with chronic thromboembolic pulmonary hypertension with rivaroxaban. International journal of cardiology, 2013, Jul-31, Volume: 167, Issue:2 Topics: Adult; Anticoagulants; Chronic Disease; Female; Humans; Hypertension, Pulmonary; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Treatment Outcome	2013
Is rivaroxaban noninferior to standard warfarin therapy in preventing recurrent PE and DVT? American family physician, 2013, Jun-15, Volume: 87, Issue:12 Topics: Anticoagulants; Female; Humans; Male; Morpholines; Pulmonary Embolism; Thiophenes	2013
Safe-dose thrombolysis plus rivaroxaban for moderate and severe pulmonary embolism: drip, drug, and discharge. Clinical cardiology, 2014, Volume: 37, Issue:2 Topics: Administration, Oral; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Morpholines; Patient Discharge; Pulmonary Embolism; Recurrence; Risk Factors; Rivaroxaban; Severity of Illness Index; Thiophenes; Thrombolytic Therapy; Time Factors; Treatment Outcome	2014
New oral anticoagulants: an emergency department overview. Emergency medicine Australasia : EMA, 2013, Volume: 25, Issue:6 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Australia; Benzimidazoles; beta-Alanine; Dabigatran; Emergency Service, Hospital; Humans; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thrombosis	2013
Inaccuracy of point-of-care international normalized ratio in rivaroxaban-treated patients. The Annals of pharmacotherapy, 2013, Volume: 47, Issue:9 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Humans; International Normalized Ratio; Male; Morpholines; Point-of-Care Systems; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thrombosis	2013
[Pulmonary embolism due to interaction between rivaroxaban and carbamazepine]. Nederlands tijdschrift voor geneeskunde, 2013, Volume: 157, Issue:52 Topics: Anticoagulants; Anticonvulsants; Arthroplasty, Replacement, Knee; Carbamazepine; Drug Interactions; Epilepsy; Humans; Male; Middle Aged; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes	2013
Treatment, monitoring, and economic outcomes of venous thromboembolism among hospitalized patients in China. PharmacoEconomics, 2014, Volume: 32, Issue:3 Topics: Anticoagulants; China; Female; Health Care Costs; Heparin, Low-Molecular-Weight; Hospitalization; Humans; International Normalized Ratio; Logistic Models; Male; Middle Aged; Morpholines; Pulmonary Embolism; Retrospective Studies; Rivaroxaban; Thiophenes; Venous Thromboembolism; Warfarin	2014
Rivaroxaban and pulmonary embolism: no better than established anticoagulant therapy. Prescrire international, 2013, Volume: 22, Issue:144 Topics: Anticoagulants; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes	2013
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism: are we ready? CJEM, 2014, Volume: 16, Issue:2 Topics: Anticoagulants; Female; Humans; Male; Morpholines; Pulmonary Embolism; Thiophenes	2014
A cost-analysis model for anticoagulant treatment in the hospital setting. Journal of medical economics, 2014, Volume: 17, Issue:7 Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Computer Simulation; Cost Savings; Cost-Benefit Analysis; Factor Xa Inhibitors; Humans; Inpatients; Length of Stay; Models, Economic; Morpholines; Pulmonary Embolism; Randomized Controlled Trials as Topic; Retrospective Studies; Rivaroxaban; Thiophenes; United States; Venous Thrombosis; Warfarin	2014
Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program. Journal of medical economics, 2014, Volume: 17, Issue:10 Topics: Adolescent; Adult; Aged; Anticoagulants; Enoxaparin; Female; Humans; Length of Stay; Male; Middle Aged; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; United States; Venous Thrombosis; Vitamin K; Young Adult	2014
Use of rivaroxaban in a patient with history of nephrotic syndrome and hypercoagulability. The Annals of pharmacotherapy, 2014, Volume: 48, Issue:12 Topics: Administration, Oral; Adolescent; Anticoagulants; Factor Xa Inhibitors; Female; Humans; International Normalized Ratio; Morpholines; Nephrotic Syndrome; Pulmonary Embolism; Rivaroxaban; Thiophenes; Thrombophilia; Venous Thromboembolism; Warfarin	2014
New way to individualize pulmonary embolism initial anticoagulant treatment-using adequate approved doses of rivaroxaban. The American journal of emergency medicine, 2014, Volume: 32, Issue:11 Topics: Dose-Response Relationship, Drug; Factor Xa Inhibitors; Humans; Morpholines; Practice Guidelines as Topic; Pulmonary Embolism; Rivaroxaban; Thiophenes	2014
[Nephrotic syndrome revealed by pulmonary embolism: about four cases]. Annales de cardiologie et d'angeiologie, 2014, Volume: 63, Issue:5 Topics: Adult; Aged; Antithrombin III; Delayed Diagnosis; Drug Therapy, Combination; Echocardiography, Doppler; Fatal Outcome; Female; Humans; Kidney Function Tests; Male; Middle Aged; Morpholines; Nephrotic Syndrome; Prednisone; Proteinuria; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thrombosis	2014
Anticoagulant treatment in German family practices - screening results from a cluster randomized controlled trial. BMC family practice, 2014, Oct-25, Volume: 15 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Coumarins; Dabigatran; Family Practice; Female; Germany; Guideline Adherence; Heart Diseases; Heart Valve Prosthesis; Humans; International Normalized Ratio; Male; Mass Screening; Middle Aged; Morpholines; Practice Guidelines as Topic; Process Assessment, Health Care; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Thrombosis; Venous Thromboembolism	2014
[Standard and new regimens of anticoagulation for pulmonary thromboembolism]. Khirurgiia, 2014, Issue:10 Topics: Anticoagulants; Blood Coagulation; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Heparin; Heparin, Low-Molecular-Weight; Humans; Morpholines; Outcome Assessment, Health Care; Patient Selection; Pulmonary Embolism; Risk Adjustment; Rivaroxaban; Thiophenes	2014
The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study. The American journal of gastroenterology, 2015, Volume: 110, Issue:2 Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Enoxaparin; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Ischemic Attack, Transient; Longitudinal Studies; Male; Middle Aged; Morpholines; Patient Readmission; Prospective Studies; Pulmonary Embolism; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Venous Thrombosis; Warfarin; Withholding Treatment	2015
[Extended options of anticoagulant treatment in thromboembolism]. Vnitrni lekarstvi, 2014, Volume: 60, Issue:11 Topics: Administration, Oral; Aged; Antithrombins; Benzimidazoles; beta-Alanine; Czech Republic; Dabigatran; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Venous Thrombosis	2014
Use of rivaroxaban could trim hospital spending in treating pulmonary embolism. The American journal of managed care, 2014, Volume: 20, Issue:8 Spec No. Topics: Administration, Oral; Cardiology; Congresses as Topic; Drug Therapy, Combination; Factor Xa Inhibitors; Fibrinolytic Agents; Heparin; Hospitalization; Humans; Infusions, Intravenous; Length of Stay; Morpholines; Pulmonary Embolism; Rivaroxaban; Societies, Medical; Thiophenes	2014
[New ESC guideline takes NOAK into account]. MMW Fortschritte der Medizin, 2015, Jun-11, Volume: 157, Issue:11 Topics: Acute Disease; Anticoagulants; Guideline Adherence; Heparin; Humans; Morpholines; Pulmonary Embolism; Risk Assessment; Rivaroxaban; Thiophenes; Vitamin K	2015
[The changes of vascular active substances in pulmonary embolism rats and a comparative study of anticoagulant drugs]. Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2015, Volume: 31, Issue:2 Topics: Animals; Anticoagulants; Disease Models, Animal; Endothelin-1; Heparin, Low-Molecular-Weight; Hypertension, Pulmonary; Lung; Morpholines; Pulmonary Embolism; Rats; Rivaroxaban; Thiophenes; Warfarin	2015
Who could benefit most from treatment of acute pulmonary embolism with rivaroxaban? Commentary to the article: "Acute pulmonary embolism treatment with rivaroxaban results in a shorter duration of hospitalisation compared to standard therapy…. Kardiologia polska, 2016, Volume: 74, Issue:7 Topics: Administration, Oral; Anticoagulants; Factor Xa Inhibitors; Hospitalization; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes	2016
Response to the letter concerning the article "Acute pulmonary embolism treatment with rivaroxaban results in a shorter duration of hospitalisation compared to standard therapy…. Kardiologia polska, 2016, Volume: 74, Issue:7 Topics: Anticoagulants; Factor Xa Inhibitors; Hospitalization; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes	2016
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clinical orthopaedics and related research, 2008, Volume: 466, Issue:8 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Azetidines; Benzylamines; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Morpholines; Polysaccharides; Pulmonary Embolism; Research Design; Rivaroxaban; Thiophenes; Venous Thrombosis	2008
Rivaroxaban for thromboprophylaxis. The New England journal of medicine, 2008, Nov-13, Volume: 359, Issue:20 Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Enoxaparin; Factor Xa Inhibitors; Hemorrhage; Humans; Morpholines; Pulmonary Embolism; Risk; Rivaroxaban; Thiophenes; Venous Thromboembolism	2008
The direct factor Xa inhibitor rivaroxaban. The Medical journal of Australia, 2009, Apr-06, Volume: 190, Issue:7 Topics: Administration, Oral; Anticoagulants; Drug Interactions; Factor Xa Inhibitors; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thrombosis	2009
Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21, Issue:9 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Denmark; Diphosphonates; Dose-Response Relationship, Drug; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Pulmonary Embolism; Raloxifene Hydrochloride; Thiophenes; Venous Thromboembolism	2010
Oral rivaroxaban for symptomatic venous thromboembolism. The New England journal of medicine, 2011, 03-24, Volume: 364, Issue:12 Topics: Acute Disease; Administration, Oral; Anticoagulants; Enoxaparin; Hemorrhage; Humans; Morpholines; Pulmonary Embolism; Recurrence; Risk Assessment; Rivaroxaban; Thiophenes; Venous Thrombosis	2011
[New anticoagulants in the prevention and treatment of venous thromboembolism]. Orvosi hetilap, 2011, Jun-19, Volume: 152, Issue:25 Topics: Administration, Oral; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Drug Costs; Drugs, Investigational; Factor Xa Inhibitors; Humans; Hungary; Morpholines; Oligosaccharides; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thrombin; Venous Thromboembolism	2011
Oral direct factor Xa inhibitor gets FDA's OK. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Aug-15, Volume: 68, Issue:16 Topics: Administration, Oral; Anticoagulants; Drug Approval; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; United States; United States Food and Drug Administration; Venous Thrombosis	2011
Vertebral fractures. The New England journal of medicine, 2011, 08-18, Volume: 365, Issue:7 Topics: Bone Density Conservation Agents; Humans; Organometallic Compounds; Pulmonary Embolism; Spinal Fractures; Thiophenes; Thromboembolism	2011
[Pharmacologic heterogeneity of new anticoagulants]. Journal des maladies vasculaires, 2011, Volume: 36 Suppl 1 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Contraindications; Dabigatran; Drug Approval; Humans; Kidney; Liver; Morpholines; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; United States; United States Food and Drug Administration	2011
[New treatments for venous thromboembolic disease]. Journal des maladies vasculaires, 2011, Volume: 36 Suppl 1 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Secondary Prevention; Thiophenes; Venous Thrombosis; Warfarin	2011
Oral thromboprophylaxis in pelvic trauma: a standardized protocol. The Journal of emergency medicine, 2012, Volume: 43, Issue:4 Topics: Adult; Aged; Anticoagulants; Drug Administration Schedule; Female; Fractures, Bone; Glasgow Coma Scale; Humans; Injury Severity Score; Lower Extremity; Male; Middle Aged; Morpholines; Pelvic Bones; Pulmonary Embolism; Radionuclide Imaging; Rivaroxaban; Thiophenes; Time Factors; Ultrasonography; Venous Thrombosis; Young Adult	2012
Acute massive pulmonary thromboembolism due to acute intoxication by duloxetine: a case report. Cardiovascular toxicology, 2012, Volume: 12, Issue:3 Topics: Acute Disease; Aged; Antidepressive Agents; Blood Pressure; Depressive Disorder; Duloxetine Hydrochloride; Fatal Outcome; Female; Heart Arrest; Heart Rate; Humans; Pulmonary Embolism; Thiophenes	2012
Rivaroxaban to prevent pulmonary embolism after hip or knee replacement. Circulation, 2012, Apr-10, Volume: 125, Issue:14 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Drug Interactions; Humans; Morpholines; Postoperative Complications; Pulmonary Embolism; Rivaroxaban; Thiophenes	2012
[Therapy of pulmonary embolism. Rivaroxaban is superior to standard therapy]. MMW Fortschritte der Medizin, 2012, Apr-19, Volume: 154, Issue:7 Topics: Anticoagulants; Hemorrhage; Humans; Morpholines; Pulmonary Embolism; Randomized Controlled Trials as Topic; Rivaroxaban; Secondary Prevention; Thiophenes; Venous Thrombosis	2012
Venous thromboembolism: EINSTEIN transforms anticoagulant therapy in acute PE. Nature reviews. Cardiology, 2012, May-08, Volume: 9, Issue:7 Topics: Acute Disease; Anticoagulants; Evidence-Based Medicine; Hemorrhage; Humans; Morpholines; Pulmonary Embolism; Randomized Controlled Trials as Topic; Recurrence; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thromboembolism	2012
Oral rivaroxaban for pulmonary embolism. The New England journal of medicine, 2012, 06-28, Volume: 366, Issue:26 Topics: Anticoagulants; Female; Humans; Male; Morpholines; Pulmonary Embolism; Thiophenes	2012
Oral rivaroxaban for pulmonary embolism. The New England journal of medicine, 2012, 06-28, Volume: 366, Issue:26 Topics: Anticoagulants; Female; Humans; Male; Morpholines; Pulmonary Embolism; Thiophenes	2012
Oral rivaroxaban for pulmonary embolism. The New England journal of medicine, 2012, 06-28, Volume: 366, Issue:26 Topics: Anticoagulants; Female; Humans; Male; Morpholines; Pulmonary Embolism; Thiophenes	2012
Pneumococcal vaccines; use of rivaroxaban for DVT and PE. JAAPA : official journal of the American Academy of Physician Assistants, 2012, Volume: 25, Issue:7 Topics: Anticoagulants; Humans; Morpholines; Pneumococcal Vaccines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thrombosis	2012
[Questions--answers on the use of rivaroxaban for the treatment of venous thromboembolic disease]. Journal des maladies vasculaires, 2012, Volume: 37, Issue:6 Topics: Age Factors; Anticoagulants; Drug Interactions; Factor Xa; France; Hemorrhage; Humans; Morpholines; Pulmonary Embolism; Risk Factors; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Vitamins	2012
Optimal initial anticoagulant therapy in pulmonary thromboembolism: randomized trial suggested. The American journal of emergency medicine, 2013, Volume: 31, Issue:2 Topics: Anticoagulants; Drug Administration Schedule; Humans; Morpholines; Practice Guidelines as Topic; Pulmonary Embolism; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes	2013
Three-month subchronic intramuscular toxicity study of rotigotine-loaded microspheres in Cynomolgus monkeys. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2013, Volume: 52 Topics: Animals; Atrophy; Blood Pressure; Body Temperature; Body Weight; Bone Marrow; Dopamine Agonists; Eating; Electrocardiography; Female; Injections, Intramuscular; Macaca fascicularis; Male; Microspheres; Mortality; Organ Size; Parkinson Disease; Polyglactin 910; Prolactin; Pulmonary Embolism; Tetrahydronaphthalenes; Thiophenes; Thymus Gland; Toxicity Tests, Subchronic	2013
[Budgetary impact for the National Health System of apixaban prophylaxis of venous thromboembolism in patients undergoing total knee or hip replacement]. Revista espanola de salud publica, 2012, Volume: 86, Issue:6 Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Budgets; Cost Control; Dabigatran; Enoxaparin; Female; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Humans; Morpholines; Polysaccharides; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Spain; State Medicine; Thiophenes; Venous Thromboembolism	2012
Inhibition of cancer cell stickiness by the blocking of platelet aggregation. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1974, Mar-30, Volume: 48, Issue:15 Topics: Adhesiveness; Animals; Antineoplastic Agents; Blood Cell Count; Blood Platelets; Capillaries; Carcinoma 256, Walker; Dipyridamole; Embolism; Endothelium; Head; Head and Neck Neoplasms; Humans; Lung Neoplasms; Morpholines; Neoplasm Metastasis; Neoplasm Transplantation; Neoplastic Cells, Circulating; Piperidines; Platelet Adhesiveness; Pulmonary Embolism; Pyrimidines; Rats; Sarcoma; Thiophenes; Transplantation, Homologous; Vasodilator Agents	1974